We are live on ! Find out more
BDRX

Biodexa Pharmaceuticals
BDRX

7 hedge funds and large institutions have $228K invested in Biodexa Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

67% less capital invested

Capital invested by funds: $693K → $228K (-$465K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$94K
2
+$16.9K
3
+$70

Top Sellers

1
-$24K
2
-$3.49K
3
-$2.78K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$159K
AC
2
Armistice Capital
New York
$60.3K
GI
3
GAMMA Investing
California
$8.52K
SS
4
SBI Securities
Japan
$93
UBS Group
5
UBS Group
Switzerland
$78
HHCP
6
Hilton Head Capital Partners
South Carolina
$19
RhumbLine Advisers
7
RhumbLine Advisers
Massachusetts
$11
CIAM
8
Caitong International Asset Management
Hong Kong
$1
HF
9
HRT Financial
New York
–